Загрузка...
Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study
BACKGROUND: PATRO Children is an ongoing observational, longitudinal, non-interventional, global post-marketing surveillance study, which is investigating the long-term safety and effectiveness of Omnitrope®, a somatropin biosimilar to Genotropin®, in children with growth disturbances. The primary e...
Сохранить в:
| Опубликовано в: : | Ital J Pediatr |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5096288/ https://ncbi.nlm.nih.gov/pubmed/27809913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0302-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|